These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 12124351

  • 1. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
    Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ.
    Cancer Res; 2002 Jul 15; 62(14):4123-31. PubMed ID: 12124351
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
    Whittle C, Gillespie K, Harrison R, Mathieson PW, Harper SJ.
    Clin Sci (Lond); 1999 Sep 15; 97(3):303-12. PubMed ID: 10464055
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
    Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, Zeillinger R.
    Clin Cancer Res; 2002 Jul 15; 8(7):2253-9. PubMed ID: 12114428
    [Abstract] [Full Text] [Related]

  • 4. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo.
    Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M, Bicknell R.
    Br J Cancer; 2000 Jul 15; 83(1):63-8. PubMed ID: 10883669
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY, Poellinger L, Walker CL.
    Cancer Res; 2003 May 15; 63(10):2675-80. PubMed ID: 12750296
    [Abstract] [Full Text] [Related]

  • 6. [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma].
    Sato K, Kato T.
    Gan To Kagaku Ryoho; 1997 Feb 15; 24(4):389-94. PubMed ID: 9063473
    [Abstract] [Full Text] [Related]

  • 7. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma.
    Thelen P, Hemmerlein B, Kugler A, Seiler T, Ozisik R, Kallerhoff M, Ringert RH.
    Anticancer Res; 1999 Feb 15; 19(2C):1563-5. PubMed ID: 10365146
    [Abstract] [Full Text] [Related]

  • 8. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W, Pufe T, Kurz B, Mentlein R, Tillmann B.
    Anat Embryol (Berl); 2002 Jul 15; 205(4):263-70. PubMed ID: 12136256
    [Abstract] [Full Text] [Related]

  • 9. Expression of VEGF splice variants 144/145 and 205/206 in adult male tissues.
    Burchardt T, Burchardt M, Chen MW, Buttyan R, de la Taille A, Shabsigh A, Shabsigh R.
    IUBMB Life; 1999 Oct 15; 48(4):405-8. PubMed ID: 10632569
    [Abstract] [Full Text] [Related]

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 15; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
    Iwai A, Fujii Y, Kawakami S, Takazawa R, Kageyama Y, Yoshida MA, Kihara K.
    Mol Cell Endocrinol; 2004 Oct 29; 226(1-2):11-7. PubMed ID: 15489000
    [Abstract] [Full Text] [Related]

  • 12. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.
    Shima DT, Gougos A, Miller JW, Tolentino M, Robinson G, Adamis AP, D'Amore PA.
    Invest Ophthalmol Vis Sci; 1996 Jun 29; 37(7):1334-40. PubMed ID: 8641836
    [Abstract] [Full Text] [Related]

  • 13. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
    Chen HJ, Treweeke AT, Ke YQ, West DC, Toh CH.
    Br J Cancer; 2000 May 29; 82(10):1694-701. PubMed ID: 10817506
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B, Galuschka L, Putzer N, Zischkau S, Heuser M.
    Histopathology; 2004 Dec 29; 45(6):603-11. PubMed ID: 15569051
    [Abstract] [Full Text] [Related]

  • 15. Expression of vascular endothelial growth factor mRNA in GI-101A and HL-60 cell lines.
    Ramakrishnan R, Zell JA, Malavé A, Rathinavelu A.
    Biochem Biophys Res Commun; 2000 Apr 21; 270(3):709-13. PubMed ID: 10772888
    [Abstract] [Full Text] [Related]

  • 16. Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.
    Zhang L, Conejo-Garcia JR, Yang N, Huang W, Mohamed-Hadley A, Yao W, Benencia F, Coukos G.
    Biochem Biophys Res Commun; 2002 Apr 12; 292(4):860-8. PubMed ID: 11944893
    [Abstract] [Full Text] [Related]

  • 17. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
    Tober KL, Cannon RE, Spalding JW, Oberyszyn TM, Parrett ML, Rackoff AI, Oberyszyn AS, Tennant RW, Robertson FM.
    Biochem Biophys Res Commun; 1998 Jun 29; 247(3):644-53. PubMed ID: 9647747
    [Abstract] [Full Text] [Related]

  • 18. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H.
    Biochem J; 2003 Mar 15; 370(Pt 3):1097-109. PubMed ID: 12495433
    [Abstract] [Full Text] [Related]

  • 19. Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines.
    Tomlinson DC, L'Hôte CG, Kennedy W, Pitt E, Knowles MA.
    Cancer Res; 2005 Nov 15; 65(22):10441-9. PubMed ID: 16288035
    [Abstract] [Full Text] [Related]

  • 20. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.
    Suzuki K, Hayashi N, Miyamoto Y, Yamamoto M, Ohkawa K, Ito Y, Sasaki Y, Yamaguchi Y, Nakase H, Noda K, Enomoto N, Arai K, Yamada Y, Yoshihara H, Tujimura T, Kawano K, Yoshikawa K, Kamada T.
    Cancer Res; 1996 Jul 01; 56(13):3004-9. PubMed ID: 8674055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.